[1]陈靖 佘强.杂交手术治疗多支冠状动脉疾病的研究进展[J].心血管病学进展,2021,(1):21-25.[doi:10.16806/j.cnki.issn.1004-3934.2021.01.000]
点击复制

杂交手术治疗多支冠状动脉疾病的研究进展()
分享到：

《心血管病学进展》[ISSN:51-1187/R/CN:1004-3934]

卷:
期数:
2021年1期
页码:
21-25
栏目:
综述
出版日期:
2021-01-25

文章信息/Info

Title:
Hybrid Coronary Revascularization in Treating Multivessel Coronary Artery Disease
文章编号:
202007014
作者:
陈靖 佘强
(重庆医科大学附属第二医院心血管内科,重庆400010)
Author(s):
?Department of Cardiology,The Second Affiliated Hospital of Chongqing Medical University,Chongqing 400010,China)
关键词:
杂交手术; 多支冠状动脉疾病; 目标人群; 疗效; 不同策略比较
Keywords:
Hybrid coronary revascularization;  Multivessel coronary artery disease; Target population; Outcome; Comparison of different strategy
DOI:
10.16806/j.cnki.issn.1004-3934.2021.01.000
摘要:
多支冠状动脉疾病显著影响冠心病患者的预后，但最佳血运重建策略尚不明确。杂交手术治疗多支冠状动脉疾病安全和可行，具有良好的短中期效果。深入探讨杂交手术的目标人群、疗效和不同手术策略特点，对冠心病患者的临床治疗很有必要。
Abstract:
Multivessel coronary disease affects the prognosis of patients with coronary atherosclerotic heart disease significantly, but the best strategy of revascularization is still unclear.Hybrid coronary revascularization,which is safe and feasible to treat multivessel coronary artery disease,has good short- and medium-term outcome.It is necessary for clinical treatment of patients with coronary heart disease to investigate the target population, outcome and different surgical strategy of hybrid coronary revascularization.

参考文献/References:

[1].Hillis L,Smith PK,Anderson JL,et al. 2011 ACCF/AHA guideline for coronary artery bypass graft surgery:executive summary:a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines[J]. J Thorac Cardiovasc Surg,2012,143(1):4-34.
[2].Otsuka F,Yahagi K,Sakakura K,et al. Why is the mammary artery so special and what protects it from atherosclerosis?[J]. Ann Cardiothorac Surg,2013,2(4):519-526.
[3].Angelini GD,Wilde P,Salerno TA,et al. Integrated left small thoracotomy and angioplasty for multivessel coronary artery revascularisation[J]. Lancet,1996, 347(9003):757-758.
[4].Cohen HA,Zenati M,Smith AJ,et al. Feasibility of combined percutaneous transluminal angioplasty and minimally invasive direct coronary artery bypass in patients with multivessel coronary artery disease[J]. Circulation,1998,98(11):1048-1050.
[5].Zenati M,Cohen HA,Griffith BP. Alternative approach to multivessel coronary disease with integrated coronary revascularization[J]. J Thorac Cardiovasc Surg,1999,117:439-444;discussion 444-446.
[6].Wittwer T,Cremer J,Boonstra P,et al. Myocardial “hybrid” revascularisation with minimally invasive direct coronary artery bypass grafting combined with coronary angioplasty:preliminary results of a multicentre study[J]. Heart,2000,83(1):58-63.
[7].de Cannière D,Jansens JL,Goldschmidt-Clermont P,et al. Combination of minimally invasive coronary bypass and percutaneous transluminal coronary angioplasty in the treatment of double-vessel coronary disease:two-year follow-up of a new hybrid procedure compared with “on-pump” double bypass grafting[J]. Am Heart J,2001,142(4):563-570.
[8].Bonatti J,Schachner T,Bonaros N,et al. Simultaneous hybrid coronary revascularization using totally endoscopic left internal mammary artery bypass grafting and placement of rapamycin eluting stents in the same interventional session.The COMBINATION pilot study[J]. Cardiology,2008,110(2):92-95.
[9].Tajstra M,Hrapkowicz T,Hawranek M,et al. Hybrid coronary revascularization in selected patients with multivessel disease:5-year clinical outcomes of the prospective randomized pilot study[J]. JACC Cardiovasc Interv,2018,11(9):847-852.
[10].[10]Shen LZ,Hu SS,Wang HR,et al. One-stop hybrid coronary revascularization versus coronary artery bypass grafting and percutaneous coronary intervention for the treatment of multivessel coronary artery disease:3-year follow-up results from a single institution[J]. J Am Coll Cardiol,2013,61(25):2525-2533.
[11].[11]Puskas JD,Halkos ME,DeRose JJ,et al. Hybrid coronary revascularization for the treatment of multivessel coronary artery disease:a multicenter observational study[J]. J Am Coll Cardiol,2016,68(4):356-365.
[12].[12]G?sior M,Zembala MO,Tajstra M,et al. Hybrid revascularization for multivessel coronary artery disease[J]. JACC Cardiovasc Interv,2014,7(11):1277-1283.
[13].[13]Song ZZ,Shen LZ,Zheng Z,et al. One-stop hybrid coronary revascularization versus off-pump coronary artery bypass in patients with diabetes mellitus[J]. J Thorac Cardiovasc Surg,2016,151(6):1695-1701.e1.
[14].[14]Harskamp RE,Bagai A,Halkos ME,et al. Clinical outcomes after hybrid coronary revascularization versus coronary artery bypass surgery:a meta-analysis of 1,190 patients[J]. Am Heart J,2014,167(4):585-592.
[15].[15]Hage A,Giambruno V,Jones P,et al. Hybrid coronary revascularization versus off-pump coronary artery bypass grafting:comparative effectiveness analysis with long-term follow-up[J]. J Am Heart Assoc,2019,8(24):e014204.
[16].[16]Harskamp RE,Vassiliades TA,Mehta RH,et al.Comparative effectiveness of hybrid coronary revascularization vs coronary artery bypass grafting[J]. J Am Coll Surg,2015,221(2):326-334.e1.
[17].[17]Leacche M,Byrne JG,Solenkova NS,et al. Comparison of 30-day outcomes of coronary artery bypass grafting surgery verus hybrid coronary revascularization stratified by SYNTAX and euroSCORE[J]. J Thorac Cardiovasc Surg,2013,145(4):1004-1012.
[18].[18]Panoulas VF,Colombo A,Margonato A,et al. Hybrid coronary revascularization:promising,but yet to take off[J]. J Am Coll Cardiol,2015,65(1):85-97.
[19].[19]Ganyukov V,Kochergin N,Shilov A,et al. Randomized clinical trial of surgical vs.percutaneous vs.hybrid revascularization in multivessel coronary artery disease:residual myocardial ischemia and clinical outcomes at one year-Hybrid coronary REvascularization Versus Stenting or Surgery(HREVS)[J]. J Interv Cardiol,2020,2020:5458064.
[20].[20]Esteves V,Oliveira MAP,Feitosa FS,et al. Late clinical outcomes of myocardial hybrid revascularization versus coronary artery bypass grafting for complex triple-vessel disease:long-term follow-up of the randomized MERGING clinical trial[J]. Catheter Cardiovasc Interv,2020,Jan 10.
[21].?DOI:10.1002/ccd.28710.?Online ahead of print.
[22].[21]Giambruno V,Jones P,Khaliel F,et al. Hybrid coronary revascularization versus on-pump coronary artery bypass grafting[J]. Ann Thorac Surg,2018,105(5):1330-1335.
[23].[22]Kitahara H,Hirai T,McCrorey M,et al. Hybrid coronary revascularization:midterm outcomes of robotic multivessel bypass and percutaneous interventions[J]. J Thorac Cardiovasc Surg,2019,157(5):1829-1836.e1.
[24].[23]Balkhy HH,Kitahara H,Hirai T,et al. Residual SYNTAX score after advanced hybrid robotic totally endoscopic coronary revascularization[J]. Ann Thorac Surg,2020,109(6):1826-1832.
[25].[24]Zhao DX,Leacche M,Balaguer JM,et al. Routine intraoperative completion angiography after coronary artery bypass grafting and 1-stop hybrid revascularization results from a fully integrated hybrid catheterization laboratory/operating room[J]. J Am Coll Cardiol,2009,53(3):232-241.
[26].[25]Zhou S,Fang ZR,Xiong H,et al. Effect of one-stop hybrid coronary revascularization on postoperative renal function and bleeding:a comparison study with off-pump coronary artery bypass grafting surgery[J]. J Thorac Cardiovasc Surg,2014,147(5):1511-1516.e1.
[27].[26]Choi HJ,Kang J,Song H,et al. Comparison of coronary artery bypass graft-first and percutaneous coronary intervention-first approaches for 2-stage hybrid coronary revascularization[J]. Korean J Thorac Cardiovasc Surg,2017,50(4):247-254.
[28].[27]Bagiella E. Hybrid Coronary Revascularization Trial[EB/OL]. ClinicalTrials.govIdentifier:NCT03089398.https://clinicaltrials.gov/ct2/show/NCT03089398,
[29].assessed September 23,2019.

相似文献/References:

[1]龚勇泉?农巍?吴先球?卢天成?韦成信.弓部受累的主动脉病变治疗应用进展[J].心血管病学进展,2023,(7):658.[doi:10.16806/j.cnki.issn.1004-3934.2023.07.019]
　GONG Yongquan,NONG Wei,WU Xianqiu,et al.Treatment of Aortic Diseases Involving Arch[J].Advances in Cardiovascular Diseases,2023,(1):658.[doi:10.16806/j.cnki.issn.1004-3934.2023.07.019]
[2]丁长柏 王健 游昕.二尖瓣环钙化临床研究及外科治疗进展[J].心血管病学进展,2024,(7):642.[doi:10.16806/j.cnki.issn.1004-3934.2024.07.015]
　DING Changbai,WANG Jian,YOU Xin.Clinical Research and Surgical Treatment of Mitral Annular Calcification[J].Advances in Cardiovascular Diseases,2024,(1):642.[doi:10.16806/j.cnki.issn.1004-3934.2024.07.015]

更新日期/Last Update: 2021-03-18